Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India
The company will work with new local contract manufacturers in India to boost supply of its key medicines.
FDA launches generics pilot program, advances facility PreCheck proposal in bid to incentivize US drug manufacturing
The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry
Cidara snares up to $339M from BARDA to bankroll its non-vaccine flu candidate
The initial part of the up-to-$339 million funding will largely be used to establish U.S. manufacturing for the non-vaccine flu preventive candidate, with additional options tied to further clinical studies, Cidara said.
Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher’s N.C. production facility
Vaxcyte is paying Thermo Fisher Scientific up to $1 billion to access vaccine fill-finish capacity at the CDMO’s production facility in Greenville, North Carolina. Vaxcyte positioned the deal as a “long-term U.S.
Ansa snares $54.4M in series B financing to boost its DNA synthesis platform
Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B financing round that will be used to expand the company’s DNA synthesis production capacity in the U.S.
Redesigning Healthcare for a Sustainable Tomorrow
In an increasingly complex global healthcare landscape, cross-sector collaboration has become essential to solving the systemic challenges we face in the medical device industry. The future of healthcare will be defined not
The Hidden Cost of Siloed Hardware and Firmware in MedTech
Medical device innovation is complex by nature, but many of the most persistent problems in product development are avoidable. One of the most common and costly mistakes in terms of both time
GeniPhys receives FDA clearance for self-assembling collagen scaffold
INDIANAPOLIS – GeniPhys, a medtech innovator specializing in next-generation regenerative collagen polymeric biomaterials, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, Collymer Self-Assembling Scaffold (SAS).
Lean AI: Accelerate Engineering with AI and Lean Principles
Artificial Intelligence (AI) has become a pervasive topic, with narratives frequently oscillating between its potential to enhance the quality of life and its potential to displace human labor. It is probable that
Healthcare’s silent burden: Why interoperability is the key to meeting patient demand
Insights shared by industry relative to healthcare and the advancement of medical technology. Christoph Lippuner is Co-Founded & CEO of Semble Christoph Lippuner co-founded Semble after witnessing the challenges of a fragmented